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Human cytomegalovirus proteins alter host cells to
favor virus replication. These viral proteins include
pUL38, which prevents apoptosis. To characterize
the mode of action of pUL38, we modified the viral
genome to encode an epitope-tagged pUL38 and
used rapid immunoaffinity purification to isolate
pUL38-interacting host proteins, which were then
identified by mass spectrometry. One of the cellular
proteins identified was TSC2, a constituent of the
tuberous sclerosis tumor suppressor protein com-
plex (TSC1/2). TSC1/2 integrates stress signals and
regulates the mammalian target of rapamycin com-
plex 1 (mTORC1), a protein complex that responds
to stress by limitingprotein synthesis andcell growth.
Weshowed that pUL38 interactswith TSC1andTSC2
in cells infected with wild-type cytomegalovirus.
Furthermore, TSC1/2 failed to regulate mTORC1 in
cells expressing pUL38, and these cells exhibited
the enlarged size characteristic of cytomegalovirus
infection. Thus, pUL38 supports virus replication at
least in part by blocking cellular responses to stress.
INTRODUCTION
Human cytomegalovirus (HCMV) is a member of the b-herpesvi-
rus family. Infections in healthy children and adults are generally
asymptomatic, but the virus causes life-threatening disease
in immunologically immature or compromised individuals (re-
viewed in Mocarski et al., 2007). Congenital HCMV infection is
the leading viral cause of birth defects, and neonates can suffer
serious complications following infection. HCMV is a major com-
plication in immunosuppressed individuals, with a significant
contribution to morbidity and mortality in allogeneic transplant
recipients and AIDS patients.
The HCMV genome contains >200 open reading frames,
although many have not been demonstrated to encode proteins
(Murphy et al., 2003a, 2003b). Upon infection of a permissive cell,
HCMV expresses its genes in a regulated cascade; immediate-Cearly genes are expressed first, followed by early and then late
genes. The UL38 transcription unit is first expressed during the
earlyphaseof infection (reviewed inMocarskietal. (2007).Amutant
virus lacking pUL38 induces apoptosis after infection, producing
reduced levels of viral progeny (Terhune et al., 2007). The mecha-
nism by which pUL38 blocks apoptosis and facilitates HCMV
growth isunknown.ABLASTsearchofpUL38revealsnosequence
homology to cellular proteins, andmoresophisticatedsearches for
functional homologies also failed to provide compelling hints to its
mode of action (Novotny et al., 2001; Rigoutsos et al., 2003).
To probe the role of pUL38, we screened for proteins that
interact with it. We used a mutant virus, expressing an epi-
tope-tagged pUL38 protein from its normal context in the viral
genome, coupled with a rapid one-step immunoaffinity purifica-
tion and mass spectrometry to identify interacting proteins. This
combination of proteomics and genetics identified multiple viral
and cellular proteins likely to interact with pUL38, one of which is
TSC2, also known as tuberin.
TSC2andTSC1 (hamartin) interact to form the tuberoussclerosis
proteincomplex (TSC1/2), andmutations ineithersubunit are linked
to the development of tuberous sclerosis, a recessive disorder that
is characterized by tumors in multiple organs (reviewed in Crino
et al., 2006). TSC1/2 is regulated by multiple signaling pathways
(reviewed inKwiatkowski andManning, 2005). Growth factors acti-
vate Akt and RSK1, which phosphorylate TSC2 and block its activ-
ity. Stress activates AMP kinase (AMPK), which phosphorylates
TSC2 and activates it. When the TSC1/2 complex is activated,
TSC2 functions as a GTPase-activating protein for Rheb, a GTP-
binding protein that activates the mammalian target of rapamycin
complex 1 (mTORC1). mTORC1 is comprised of at least three
subunits, mTOR serine-threonine kinase, raptor, and gbL, and it
regulates cell growth in response to growth factors and nutrient
availability. mTORC1 controls cell growth by modulating multiple
processes, including protein synthesis, ribosome biogenesis, and
autophagy (reviewed in Sarbassov et al., 2005a). Thus, TSC1/2 in-
terprets signals from multiple inputs, and when activated, it is a
negative regulator of mTORC1 and thereby inhibits cellular growth.
We confirmed the interaction of pUL38with the tumor suppres-
sor protein complex and demonstrated that the viral protein
antagonizes the ability of TSC1/2 to negatively regulatemTORC1.
Thus, pUL38 blocks a growth regulatory pathway to facilitate viral
replication.ell Host & Microbe 3, 253–262, April 2008 ª2008 Elsevier Inc. 253
Cell Host & Microbe
HCMV pUL38 Antagonizes the TSC1/2 Protein ComplexRESULTS
Identification of Candidate pUL38-Interacting Partners
To identify cellular andviral proteins that interactwithpUL38 in the
context of infection, we created a viral mutant, BADinUL38TAP,
which expresses from its normal location on the viral genome
the pUL38 protein fused to immunoglobulin-binding domains of
protein A and a calmodulin-binding peptide (TAP) at its carboxyl
terminus, pUL38TAP (Figure 1A, left). Mutations disrupting the
UL38 ORF result in attenuated virus replication with a rapid onset
of apoptosis (Terhune et al., 2007). BADinUL38TAP replicated to
wild-type levels (Figure1A, right), andpUL38TAPdisplayedasim-
ilar localization as observed for untagged pUL38 when assayed
by immunofluorescence (Figure 1B). Tagged pUL38 (from BADi-
nUL38TAP) and untagged pUL38 (from BADWT) were found in
both the cytoplasm and nucleus at 24 hr after infection. The
pUL38 TAP fusion does not disrupt the localization or an essential
role of pUL38 in HCMV-infected fibroblasts.
At 24 hr postinfection with BADinUL38TAP, pUL38TAP and
associated proteins were isolated from cell extracts. By capturing
complexes from cells infected with the HCMV variant, it was pos-
sible to identify pUL38-interacting proteins under conditions
where pUL38 is expressed with proper kinetics and at normal
levels. Isolations were performed via the protein A tag, using
a rapid one-step immunoaffinity purification on magnetic beads
coated with IgG (Cristea et al., 2005, 2006). pUL38TAP was effi-
ciently captured with little of the fusion protein remaining in the
insoluble fraction (data not shown). Isolated viral andhost proteins
were resolved by electrophoresis, stained with Coomassie blue,
and identifiedbymass spectrometry. Themajor protein bands ev-
ident in thepolyacrylamidegel and illustrativedata fromsequential
MALDI QqTOF MS and MALDI IT MS/MS analysis for one of the
identified cell proteins, TSC2, are displayed in Figure 1C. The full
set of identifiedproteins is presented inTableS1 (availableonline).
Two HCMV proteins were identified in the capture experiment
(Table S1). The first was pUL52, and the secondmigrated at70
kDa (Figure 1C). The latter contained amino acid segments from
the adjacent UL29 and UL28 ORFs. NetGene2 (http://www.cbs.
dtu.dk/services/NetGene2/; Brunak et al., 1991) predicted
a splice donor/acceptor motif that would generate a mRNA
encoding a UL29/28 protein of 701 amino acids, consistent
with its electrophoretic migration. The product of UL52 is essen-
tial, while the UL29 and 28 ORFs augment HCMV replication in
fibroblasts (Yu et al., 2003). However, their functions are un-
known, and we have not investigated the consequences of their
predicted interactions with pUL38.
Numerous cellular proteins were identified in the capture
experiment (Figure 1C and Table S1). Although their capture sug-
gests that pUL38might influencemultiple cell functions, we have
so far confirmed only one of these interactions. The list, there-
fore, comprises potential pUL38-interacting proteins. It is intri-
guing that six subunits of the nucleosome remodeling and
histone deacetylation (NuRD) complex were among the proteins
captured by pUL38TAP: Mi-2b, MTA1 and 2, HDAC1 and 2, and
RbAp48/46 (Figure 1C). The NuRD complex includes histone
deacetylases and chromatin-remodeling ATPases, which
repress transcription (Bowen et al., 2004). It is possible that
pUL38 antagonizes NuRD to optimize expression of the viral ge-
nome. The HCMV immediate-early 1 (Nevels et al., 2004) and
Figure 1. Process for Identification of pUL38 Binding Partners
during HCMV Infection
(A) Construct mutant virus with tagged protein and confirm its normal growth.
The top line of the diagram to the left locates the UL38 ORF within the unique
long (UL) domain of the viral genome; the second line shows the location of the
UL38ORF betweenUL37 exons; the third line illustrates the fusion of a TAP tag
to the C terminus of pUL38 and the position of a FLP recombinase target (FRT)
sequence introduced with the TAP sequence in BADinUL38TAP. Arrowheads
mark the C termini of ORFs. Yields (IU, infectious units determined by assay for
HCMV IE1 protein fluorescence at 48 hpi) were determined for BADWT and
BADinUL38TAP at 0 (immediately after virus adsorption), 5, and 10 days
postinfection (dpi) of fibroblasts (0.01 pfu/cell). Yields are from two indepen-
dent experiments assayed in duplicate (n = 4); error bars denote ± 1 standard
error of the mean.
(B) Confirmproper localization of the tagged protein at 24 hr postinfection (hpi).
pUL38 and pUL38TAP localizations (green) were determined after infec-
tion with BADWT or BADinUL38TAP, respectively. For wild-type pUL38,
anti-pUL38 antibody was used for immunofluorescence, while IgG was used
to visualize pUL38TAP. Lectin HPA (red) stains the Golgi, and DAPI (blue)
stains nuclear DNA. Uninfected cells surround infected cells.
(C) Identify interacting proteins at 24 hpi. pUL38TAP-interacting proteins were
isolated by immunoaffinity purification, separated by gel electrophoresis, and
identified by sequential MS and MS/MS analysis. The positions of key
captured proteins as well as pUL38TAP and free TAP tag (CTAP) are indicated.
*Nonspecific contaminants. zBecause of the similarity of the sequences of
RbAp48 and RBAp46, either or both may be present.
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deacetylase function, and other herpesviruses (e.g., Gu et al.,
2005) attack repressive chromatin-modifying complexes as well.
We focused on the predicted interaction of pUL38 with TSC2,
a component of the TSC1/2 tumor suppressor protein complex.
TSC1/2 regulates mTORC1, which is deregulated by HCMV
infection (Kudchodkar et al., 2004). This led to the hypothesis
that pUL38 binds to TSC1/2 and antagonizes its ability to regu-
late mTORC1.
Characterization of the pUL38 Interaction
with TSC2 and TSC1
To confirm the putative pUL38-TSC2 interaction, we reversed
the capture process used in the pUL38TAP immunoaffinity
purification, and used antibodies specific for cellular proteins
to test for coimmunoprecipitation of pUL38 from wild-type
virus-infected cell extracts. A TSC2-specific antibody coprecipi-
tated pUL38 from infected cells, but not mock-infected cells
(Figure 2A, top panel). No pUL38was detected after immunopre-
cipitation from the infected cell extract with preimmune IgG, and
the use of wild-type virus ruled out a nonspecific interaction of
TSC2 with the TAP component of pUL38TAP. The thickness of
the pUL38 band detected in Figure 2A suggested that multiple
species might be present, so the analysis was repeated using
a higher-resolution electrophoresis protocol (Figure 2B). Three
pUL38-specific bands were evident, corresponding to proteins
of approximately 33, 35, and 37 kDa. All three isoforms are found
in cells expressing only pUL38 (Figure 4A), indicating that the
three species are specific to the UL38 ORF. We do not yet
know the origin of the three species but note that there are three
in-frame AUG codons that could code for proteins this size, and
there is precedent in HCMV for use of multiple in-frame starts
within an ORF (Stamminger et al., 2002). Antibody to TSC2
preferentially coprecipitated the pUL38 37 kDa isoform and to
a lesser extent the 35 kDa species (Figure 2B).
TSC2 interactswith TSC1 to form the tumor suppressor protein
complex TSC1/2. To determinewhether pUL38 also interacts, di-
rectly or indirectly,withTSC1, the same set of lysates examined in
Figure2Aweresubjected to immunoprecipitationwithantibody to
pUL38 (Figure2C, toppanel). pUL38-specific immunecomplexes
isolated fromBADWT-infected cells contained TSC1 protein, and
this interaction was found to be specific using the same criteria
outlined above for TSC2. A similar experiment demonstrated
that antibody to TSC1 can coprecipitate pUL38 (Figure 2D).
To determine whether pUL38 can interact with each of the
TSC1/2 subunits independently, 293T cells were transfected
with a pUL38 expression vector plus constructs encoding
FLAG-tagged TSC1 and/or FLAG-tagged TSC2. pUL38 was co-
precipitated with tagged TSC2 but not TSC1 (Figure 2E), arguing
that the viral protein does not interact with free TSC1. To further
probe the interaction of the viral protein with TSC2, cells were
Figure 2. Confirmation of the Interaction between pUL38 and the
TSC1/2 Protein Complex
Fibroblasts weremock infected (M) or infectedwith BADWT (WT) (3 pfu/cell), or
293T cells were transfected with indicated expression vectors. Results are
representative of two independent experiments.
(A) pUL38 coprecipitates with TSC2. Cell lysates were prepared at 48 hr after
mock or BADWT infection and subjected to immunoprecipitation (IP) using
rabbit polyclonal antibody to TSC2 (a-TSC2), control preimmune rabbit IgG
(C Ab), or beads with no antibody (No Ab), and precipitated proteins were
analyzed by western blot (WB) using the indicated antibodies. As controls,
the levels of TSC2 and pUL38 were monitored by western blot assay.
(B) Two pUL38 isoforms coprecipitate with TSC2. To improve the separation of
pUL38 isoforms present at 48 hr postinfection, electrophoresis was performed
using a larger-format polyacrylamide gel. Left lanes: western blots (WB) were
performed on mock-infected and virus-infected lysates using antibody to
pUL38; right lanes: western blots were performed after immunoprecipitation
(IP) from lysates using a-TSC2 or preimmune rabbit IgG (C Ab).
(C) TSC1 coprecipitates with pUL38. Extracts were prepared at 48 hr after
mock or BADWT infection, and immunoprecipitations were performed using
antibody to pUL38 (a-pUL38), a nonspecific monoclonal antibody (C Ab), or
beads with no antibody (No Ab).
(D) pUL38 coprecipitates with TSC1. Extracts were prepared at 48 hr after
mock or BADWT infection, and immunoprecipitations were performed using
antibody to TSC1 (a-TSC1), a nonspecific monoclonal antibody (C Ab), or
beads with no antibody (No Ab).
(E) pUL38 coprecipitates with FLAG-TSC2 but not FLAG-TSC1. Cells were
transfected with vectors expressing the indicated proteins, extracts were
prepared 48 hr later, and immunoprecipitations were performed by using
FLAG epitope-specific antibody.
(F) pUL38 coprecipitates with EGFP-TSC2DHBD. Cells were transfected with
vectors expressing the indicated proteins, extracts were prepared 48 hr later,
and immunoprecipitations were performed by using GFP-specific antibody.
(G) TSC1 and TSC2 coimmunoprecipitate with pUL38. Lysates were prepared
at indicated times after mock or BADWT infection (hr postinfection [hpi]),
immunoprecipitated using antibody to TSC2, and assayed by western blot
using antibodies to the indicated proteins. Lysates were also assayed directly
by western blot.
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encoding GFP-tagged TSC2 or a GFP-tagged derivative of
TSC2 lacking the TSC1 interaction domain (Goncharova et al.,
2004). The deleted TSC2 was, as expected, smaller than the
wild-type protein, and immunoprecipitation of the TSC2 variant
with GFP-specific antibody coprecipitated pUL38 (Figure 2F).
We conclude that pUL38 interacts with the tumor suppressor
complex primarily through its TSC2 subunit. A direct interaction
with TSC2, but not TSC1, might explain the failure to detect
TSC1 in our analysis of pUL38TAP-interacting proteins by
mass spectrometry (Table S1). Perhaps the TSC1/2 complex is
disrupted during the one-step isolation method.
Since pUL38 can interact with a TSC2 variant lacking a TSC1-
binding domain, it is likely that pUL38 does not disrupt the TSC1/
2 complex. To verify this prediction, we tested whether normal
levels of the TSC1/2 complex were maintained in infected cells
(Figure 2G). Cell lysates were prepared after mock or BADWT
infection and subjected to immunoprecipitation with antibody
to TSC2, and coprecipitated TSC1 was monitored by western
blot assay. TSC1 was present in TSC2 immune precipitates at
each time assayed after infection. In fact, more TSC1 was found
associated with TSC2 at 72 and 96 hpi, consistent with the in-
creaseobserved in the total amount of TSC1; in contrast, the level
of TSC2 remained relatively constant after infection. In a recent
high-throughput analysis, TSC1 protein was shown to increase
by a factor of 3.1 after HCMV infection (Stanton et al., 2007).
To further investigate the interaction of pUL38 with the TSC1/2
complex, we performed immunofluorescent analysis. Visual
inspection of the fluorescent images suggested that TSC1 and
TSC2 exhibited substantial colocalization within uninfected and
infected cells (Figure 3), and quantitative measurement of the
images (Costes et al., 2004) confirmed the colocalization, demon-
strating that Pearson’s correlation (r) for colocalization was even
greater in infected (r = 0.79) than uninfected cells (r = 0.65). This
difference was consistently observed in multiple images (data
not shown). Perfect colocalization was evident when a TSC1 fluo-
rescent image was compared to itself (r = 1.0), and little was
evident when cytoplasmic virus-coded pUL99 protein was com-
pared to DAPI-stained DNA (r = 0.06). We infer that pUL38 does
not significantlydisrupt thenormal associationof TSC1andTSC2.
pUL38 Blocks TSC1/2 Function, Antagonizing
Its Regulation of mTORC1
Since TSC1/2 normally inhibits the mTORC1 kinase under stress
conditions, limiting cell size and mass (Sarbassov et al., 2005a),
we testedwhether pUL38 can release this constraint. Fibroblasts
were generated expressing pUL38 (HFF-pUL38) or GFP (HFF-
GFP). Initially, we compared pUL38 expression in HFF-pUL38
cells to that in fibroblasts at 48 hr after infection with BADWT
(Figure 4A). Western blot analysis demonstrated that similar
Figure 3. Colocalization of TSC1 and TSC2 in Infected Fibroblasts
Immunofluorescent analysis at 24 hr postinfection with BADinUL99GFP, a
variant that contains a GFP tag at the C terminus of the UL99 ORF. The field
contains both an uninfected (Uninf) and infected (Inf) cell identified by GFP
expression. Antibodies were employed to identify TSC2 (purple) and TSC1
(red), and DNA was stained with DAPI.
Figure 4. Fibroblasts Expressing pUL38 Are Larger Than Normal
Fibroblasts
(A) Three isoforms of pUL38 are expressed in the absence of infection.
Extracts of HFF-pUL38 cells and fibroblasts at 48 hr postinfection with BADWT
were assayed by western blot using antibody to pUL38. a-tubulin was
monitored as a loading control.
(B) pUL38 interacts with TSC2 in the absence of infection. Extracts were pre-
pared from HFF-pUL38 or control HFF-GFP cells, immunoprecipitations (IP)
were performed using rabbit antibody to TSC2 (a-TSC2) or control preimmune
rabbit antibody (C Ab), and western blot (WB) assays utilized the indicated
antibodies. The results are representative of two independent experiments.
(C) Assay of cell volume by quantification of fluorescent intensity in HFF-GFP
versus HFF-pUL38 cells. Cells were loaded with calcein green AM; complete
z-stacks (0.3 mm slices) were collected for individual, fluorescent cells; and
volumes were calculated. Ten well-isolated cells of each type were analyzed,
and bars mark average cell volumes.
(D) Assay of relative cell volume by forward scatter of HFF-GFP versus
HFF-pUL38 cells. Forward scatter of53 105 cells per sample wasmeasured
by flow cytometry.
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pUL38 and tubulin were monitored as controls, and results are representative of two or three independent experiments.
(A) Subconfluent HFF-pUL38 (+pUL38) or control HFF-GFP cells (pUL38) were cultured with (+S) or without (S) serum for 12 hr. Some S cultures were
switched to PBS for 1 or 2 hr, after which cells were harvested, lysates were prepared, and protein was analyzed by western blot assay using antibodies specific
for rpS6 phosphorylated at S235/236 and total rpS6.
(B) Subconfluent +pUL38 and pUL38 cells were maintained in serum-free medium for 12 hr, and the medium was replaced with PBS for 2 hr in the presence or
absence of Rapamycin (Rapa, 20 nM). Proteins were assayed by western blot using antibodies specific for indicated phosphorylated proteins or that recognize
proteins irrespective of phosphorylation state.
(C) Subconfluent +pUL38 andpUL38 cells were maintained in serum-free medium (S) for 12 hr, then AICAR (AMPK activator, 5 mM) was added to a portion of
the cultures, and cells were harvested 1, 3, or 6 hr later. Assays were as described in (A).
(D) Subconfluent +pUL38 andpUL38 cells weremaintained in serum-free medium for 12 hr, then AICARwith or without rapamycin was added to a portion of the
cultures, and cells were harvested 6 hr later. Assays were as described in (A).
(E) Subconfluent +pUL38 andpUL38 cells weremaintained in serum-freemedium for 12 hr, then AICARwith or without rapamycin was added to a portion of the
cultures, and cells were harvested 6 hr later. Proteins were assayed bywestern blot using antibodies specific for acetyl CoA carboxylase (ACC) phosphorylated at
S79 and total ACC.amounts of pUL38 and the same variety and relative proportions
of pUL38 subspecies were produced in cells expressing the
protein as in infected cells. Further, antibody to TSC2 coim-
munoprecipitated pUL38 from extracts of HFF-pUL38 cells
(Figure 4B, top panel), demonstrating that no additional virus-
coded protein is needed for the interaction. TSC2-specific anti-
body also coimmunoprecipitated TSC1 (Figure 4B, second panel
from top), consistent with our interpretation that the TSC1/2
complex remains intact in the presence of pUL38. Western blot
assays demonstrated that extracts of HFF-pUL38 and HFF-
GFP cells contained very similar amounts of TSC1 and TSC2
(Figure 4B, bottom panels). The failure to modulate TSC1 levels
in the presence of pUL38 suggests that one or more additional
virus-coded functions is needed for the induction observed in
infected cells (Figure 2).
Cell volumes were assayed by measurement of calcein green
AM fluorescence in sequential 0.3 mm optical sections through
cells, and the average volume calculated for HFF-pUL38 cells
was about twice that of HFF-GFP cells (Figure 4C). Further, mea-
surement of forward scatter by flow cytometry confirmed that
HFF-pUL38 cells are larger than HFF-GFP cells (Figure 4D).
Thus, pUL38-expressing cells were larger than control cells,
consistent with the inhibition of TSC1/2 (Fingar et al., 2002).As noted above, TSC1/2 inhibits the activity of mTORC1 in
response to stress. TSC2 is activated when serum is withdrawn
from cells, because the loss of growth factors inhibits PI3K-Akt
and ERK1/2-RSK1 signaling, which normally block TSC1/2
activity; TSC2 is also activated by the withdrawal of nutrients,
because energy deprivation activates AMPK, which then acti-
vates TSC1/2 (Figure 7) (Kwiatkowski and Manning, 2005).
When activated, mTORC1 phosphorylates the ribosomal protein
S6 kinase (p70 S6 kinase) and eukaryotic initiation factor 4E
binding protein 1 (4E-BP1) (Sarbassov et al., 2005a). To further
evaluate the ability of pUL38 to antagonize TSC1/2, we moni-
tored the activity of mTORC1 in control or HFF-pUL38 cells after
nutrient stress. Initially, the phosphorylation of rpS6 at S235/236,
a target of the mTORC1-activated p70 S6 kinase, was assayed
by using antibodies that recognized total or phosphorylated
rpS6 (Figure 5A). Maintenance in medium lacking growth factors
for 12 hr induced a modest decrease in total rpS6 in both cell
types, and HFF-pUL38 cells accumulated 2.5-fold more phos-
phorylated rpS6 than HFF-GFP cells. Incubation in PBS (no
growth factors, amino acids, or sugars) for 1 hr after the initial
12 hr period in medium lacking serum resulted in a dramatic
reduction in the amount of phosphorylated rpS6 in HFF-GFP
cells. In contrast, HFF-UL38 cells contained near wild-type levelsCell Host & Microbe 3, 253–262, April 2008 ª2008 Elsevier Inc. 257
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tein was still detected, albeit at a reduced level, after 2 hr
(Figure 5A). Continued phosphorylation of rpS6 in HFF-pUL38
cells after maintenance in PBS was dependent on rapamycin-
sensitive mTORC1 activity (Figure 5B). We extended the analysis
to direct targets of mTORC1 and found that phosphorylation of
both p70 S6 kinase at T389 and 4E-BP1 at T37/46 was more
resistant to a 2 hr incubation in PBS, following 12 hr in serum-
free medium, in cells expressing pUL38 as compared to control
cells (Figure 5B). Thus, pUL38 alone is sufficient to maintain
mTORC1 signaling under stress-inducing conditions.
Phosphorylation of 4E-BP1 T37/46 was more resistant to
rapamycin in pUL38-expressing as compared to control cells
(Figure 5B). The mechanistic basis for this observation is not
clear, but it has been noted that HCMV-infected cells contain
a rapamycin-resistant raptor-containing activity (raptor is a
constituent of the normally rapamycin-sensitive mTORC1 com-
plex) that can mediate hyperphosphorylation of 4E-BP1 (Kud-
chodkar et al., 2006). Nevertheless, rapamycin treatment at the
start of infection delays the production of virus progeny by about
12 hr and reduces the final yield of virus by a factor of 5–50 in the
presence or absence of serum (Kudchodkar et al., 2004).
Limiting nutrients induce an increase in the AMP/ATP ratio in
the cell. AMP binds to and allows activation of AMPK, which
can phosphorylate and activate TSC2 with subsequent inhibition
of mTORC1 activity. Thus, AMPK negatively regulates mTORC1
through TSC1/2. AMPK also can be activated by the cell-perme-
able AMP analog AICAR. AICAR treatment decreases mTORC1
activity and induces cell growth arrest (Corton et al., 1995). We
tested the ability of pUL38 to block the inhibition of mTORC1
activity by AMPK, using AICAR to stimulate AMPK activity. Se-
rum-starved HFF-GFP control cells or HFF-pUL38 cells were
treated with AICAR, and mTORC1 activity was assessed by
measuring rpS6 phosphorylation at S235/236. Phosphorylated
rpS6 was markedly reduced in HFF-GFP as compared to HFF-
pUL38 cells after 3 hr or 6 hr of drug treatment (Figure 5C). The
6 hr AICAR treatment was repeated in the presence or absence
of rapamycin (Figure 5D, top two panels). AICAR-induced phos-
phorylation of rpS6 was sensitive to the inhibitor, confirming that
pUL38 preserved the activity of rapamycin-sensitive mTORC1.
The concentration of AICAR used in these experiments induced
phosphorylation at S79 of a known AMPK target, acetyl-CoA
carboxylase (Figure 5E), demonstrating that AMPK was ac-
tivated by the drug. Further, the level of phosphorylated acetyl-
CoA carboxylase was not influenced by the presence of
pUL38, arguing that pUL38 does not act at AMPK or upstream
of AMPK to influence mTORC1 function. We conclude that
pUL38 blocks the negative regulation of mTORC1 by AMPK by
inhibiting TSC1/2 function.
A second mTOR-containing complex, mTORC2, phosphory-
lates Akt at S473 (Hresko and Mueckler, 2005; Sarbassov
et al., 2005b). This modification contributes to activation of Akt
for efficient phosphorylation of some but not all of its targets
(Guertin et al., 2006; Jacinto et al., 2006). Akt S473 phosphoryla-
tion is impaired in TSC1/2-deficient cells (Yang et al., 2006), sug-
gesting that the tumor suppressor regulates mTORC2, at least
under some circumstances. Accordingly, we tested whether
pUL38 influences Akt S473 phosphorylation as a consequence
of its inhibitory interaction with TSC1/2. Although, as observed
258 Cell Host & Microbe 3, 253–262, April 2008 ª2008 Elsevier Inc.previously (Jacinto et al., 2006), starvation in PBS blocked Akt
S473 phosphorylation, there was no difference in the level of
Akt S473 phosphorylation in HFF-pUL38 as compared to control
HFF-GFP cells maintained in medium containing serum
(Figure 5B, middle panels). We find no evidence for an effect of
pUL38 on mTORC2.
The effect of pUL38 on p70 S6 kinase and 4E-BP1 phosphor-
ylation in response to stress was confirmed within HCMV-
infected cells (Figure 6A). Fibroblasts were maintained in
medium lacking serum overnight and then infected with BADWT
(pUL38+) or BADdlUL38 (pUL38). After virus adsorption, the
inoculum was removed and replaced with serum-free medium,
and the phosphorylation status of mTORC1 targets was mea-
sured at 48 hpi. The level of phosphorylated p70 S6 kinase
and 4E-BP1 was substantially reduced in cells infected with
the pUL38-deficient virus. The phosphorylation of rpS6 was
monitored as measure of p70 S6 kinase activity, and its phos-
phorylation was also substantially reduced in cells infected
with pUL38-deficient virus as compared to cells infected with
wild-type HCMV at each time tested (Figure 6B).
No phosphorylated p70 S6 kinase T389was detected at 48 hpi
with the pUL38-deficient virus (Figure 6A), whereas residual
phosphorylated rpS6 S235/236 was evident at 48 and 72 hpi
(Figure 6B). Earlier work has documented rapamycin-resistant
phosphorylation of rpS6 in HCMV-infected cells in the absence
of detectable phosphorylated p70 S6 kinase T389, and this led
to speculation that the virus might induce an mTORC1-indepen-
dent kinase activity that mediates the residual rpS6 S235/236
phosphorylation (Kudchodkar et al., 2004). Perhaps we see
evidence of this kinase activity in our experiment; alternatively,
the pUL38-deficient virus-infected cells might contain a small
amount of active p70 S6K that we have failed to detect.
HCMV pUL38 is necessary (Figure 6) and sufficient (Figure 5)
to deregulate mTORC1.
Figure 6. Phosphorylation of rpS6 in Response to Stress Is
Decreased following Infection with a pUL38-Deficient Virus
As controls, pUL38 and tubulin were monitored. The results are representative
of two independent experiments.
(A) Fibroblasts were maintained for 12 hr in serum-free medium, infected with
BADWT (1 pfu/cell) or with BADdlUL38 at an equivalent number of genomes
per cell, and refed with serum-free medium. At 48 hr postinfection, cells
were harvested, and lysates prepared and analyzed by western blot using
antibodies specific for indicated phosphorylated proteins or that recognize
proteins irrespective of phosphorylation state.
(B) Fibroblasts were treated as in (A), and at the indicated hr postinfection (hpi),
cells were harvested and analyzed by western blot using antibodies specific
for total rpS6 and rpS6 phosphorylated at ser235/236.
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We used a rapid, one-step purification method (Cristea et al.,
2005) to capture epitope-tagged pUL38 expressed from the
HCMV genome and employed mass spectrometry to identify
multiple viral and cell proteins that copurified with it (Figure 1C
and Table S1). The interaction with TSC1/2 was confirmed by
using antibodies to the cellular partners to coprecipitate pUL38
from extracts of cells infected with wild-type HCMV (Figure 2).
We focused our functional analysis on the interaction of pUL38
with TSC2. Ectopic expression of pUL38 in fibroblasts increased
their size (Figures 4C and 4D). Increased cell size is a hallmark of
tumors formed in tuberous sclerosis complex and results from
constitutive mTORC1 signaling (Fingar et al., 2002; Tee et al.,
2003). Increased size is also a hallmark of HCMV-infected cells
(Gandhi and Khanna, 2004). The interaction of pUL38 with the
tumor suppressor protein complex blocked its ability to regulate
mTORC1 in response to stress in cells expressing the viral
protein outside the context of infection (Figure 5) and in virus-
infected cells (Figure 6). Limiting growth factors and nutrients
activate TSC1/2, which blocks mTORC1. In control fibroblasts,
this stress blocked phosphorylation of two direct mTORC1
targets, p70 S6K T389 and 4E-BP1 T37/46, as well as rpS6
S235/236, which is phosphorylated by activated p70 S6K
(Figures 5A and 5B). In contrast, rapamycin-sensitive mTORC1
remained significantly more active in pUL38-expressing cells
subjected to stress (Figures 5A and 5B). Further, AICAR-medi-
ated stimulation of AMPK, which activates TSC1/2 and inhibits
mTORC1, did not block phosphorylation of rpS6 in the presence
of pUL38 (Figure 5C).
The physical interaction of pUL38with TSC1/2 and the pUL38-
mediated block to stress-induced inhibition of mTORC1 activity
support the conclusion that the viral protein antagonizes the
ability of TSC1/2 to regulate mTORC1 activity. This conclusion
is consistent with earlier work showing that HCMV induces
mTORC1 activity (Kudchodkar et al., 2004, 2006) and blocks
the effect of AMPK on mTORC1 function (Kudchodkar et al.,
2007). The relevance of mTORC1 function to HCMV pathogene-
sis is underscored by multiple observations: inhibition of
mTORC1 by rapamycin antagonizes HCMV replication in
cultured cells (Kudchodkar et al., 2004); shRNA depletion of
the Raptor mTORC1 subunit inhibits virus growth (Kudchodkar
et al., 2006); and, importantly, rapamycin protects against
reactivation of HCMV in patients who have undergone allogeneic
hematopoietic stem cell transplantation (Marty et al., 2007).
How does pUL38 block TSC1/2 activity? The human papillo-
mavirus type 16 E6 protein directs the degradation of TSC2 (Lu
et al., 2004), and Kaposi’s sarcoma-associated herpesvirus
vGPCR causes phosphorylation and inactivation of TSC2 (Sodhi
et al., 2006). Further, expression of Epstein-Barr virus LMP2
protein correlates with Akt activation and hyperphosphorylation
of the mTORC1 target 4E-BP1 (Moody et al., 2005), suggesting
that this oncoprotein might also target TSC1/2. HCMV pUL38
does not reduce the level of TSC1 or TSC2 (Figure 2), it does
not contain motifs predictive of intrinsic kinase activity, and there
is no evidence for disruption of the TSC1/2 complex (Figures 2G
and 3). Perhaps the interaction of pUL38 with TSC2 (Figures 2E
and 2F) blocks an activating phosphorylation of TSC2 or
facilitates an inhibitory phosphorylation. Alternatively, pUL38could displace a component from the complex that we have
not monitored, direct an antagonistic cellular protein to the
complex, or interfere directly with the GAP activity of TSC2.
We have established that pUL38 alone is sufficient to antago-
nize the regulation ofmTORC1byTSC1/2. Additional inputs likely
cooperate with pUL38 to modulate the TSC1/2-mTORC1 re-
sponse pathway in infected cells (Figure 7). HCMV activates
phosphatidylinositol 3-kinase (PI3K) and its downstream targets,
including Akt (Johnson et al., 2001). This activation ismediated at
least in part by the HCMV immediate-early 1 and 2 proteins,
which can induce PI3K-dependent phosphorylation of Akt
(T308) outside the context of infection (Yu and Alwine, 2002).
This phosphorylation activates Akt, which can phosphorylate
and inactivate TSC2 (Kwiatkowski andManning, 2005). Similarly,
RSK1 kinase is active in HCMV-infected cells (Rodems and
Spector, 1998), and it also can phosphorylate and inactivate
TSC2 (Kwiatkowski and Manning, 2005). In addition, HCMV
blocks upstream elements of the DNA damage response, which
normally activates TSC1/2. ATM kinase, which propagates the
DNA damage response (Kastan and Bartek, 2004), is mislocal-
ized within HCMV-infected cells (Gaspar and Shenk, 2006), and
p53, which activates AMPK in response to DNA damage (Feng
et al., 2005), is inactivated after infection (Casavant et al., 2006).
The ability of pUL38 to inhibit TSC1/2 and maintain active
mTORC1 leads to predictions of additional consequences within
infected cells. mTORC1 activates p70 S6 kinase, which favors
Figure 7. HCMV Influences Multiple Cellular Pathways that Commu-
nicate with mTORC1 through TSC1/2
Activities that are known to be enhanced or inhibited by HCMV infection are
indicated by green or red boxes, respectively. Gray boxes mark activities
not known to be modified by HCMV. The ‘‘core’’ TSC1/2-mTOR pathway is
rendered in larger, bold print: TSC1/2, tuberous sclerosis complex; Rheb-
GTP, ras homolog enriched in brain protein; mTORC1, mammalian target of
rapamycin complex 1; S6K, p70 S6 kinase; 4E-BP1, eukaryotic initiation factor
4E binding protein 1; rpS6, ribosomal protein S6. Some additional activities
that impact the core pathway: ATM, ataxia-telangiectasia mutated protein;
p53, p53 tumor suppressor protein; LKB1, Peutz-Jeghers syndrome protein;
ERK1/2, extracellular signal-regulated kinase 1 and 2; RSK1, p90 ribosomal
S6 kinase 1; IRS1, insulin receptor substrate protein; PI3K, phosphoinositide
3-kinase; Akt, protein kinase B; AMPK, AMP kinase.
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et al., 1997). By maintaining active p70 S6 kinase, pUL38 might
alter translational specificity within infected cells. In a similar
vein, active p70 S6 kinase downregulates insulin receptor sub-
strates 1 and 2 (Harrington et al., 2004; Shah et al., 2004), so
pUL38 might induce insulin resistance in HCMV-infected cells.
Autophagy is regulated by mTORC1. Inhibition of mTORC1 by
rapamycin (Shintani and Klionsky, 2004) or by activation of
AMPK (Meley et al., 2006) can increase autophagy, so mainte-
nance of active mTORC1 by pUL38 might inhibit autophagy.
Finally, pUL38 might influence cell cycle status. The cyclin-
dependent kinase inhibitor p27 is a Cip/Kip family member,
and it contributes to the maintenance of cells in G0 (Coats
et al., 1996; Zhang et al., 2000). TSC2 binds to p27, stabilizing
it (Rosner and Hengstschlager, 2004), and inhibition of TSC2
expression can induce quiescent fibroblasts to enter the G1
phase of the cell cycle (Soucek et al., 1997). HCMV induces
G0 cells to enter G1, and three viral proteins, pUL82 (Kalejta
et al., 2003), immediate-early 1 (Castillo et al., 2000), and imme-
diate early 2 (Murphy et al., 2000), contribute to the induction.
Given the ability of pUL38 to block TSC1/2 function, it is possible
that it also helps tomove quiescent cells into the cycle, providing
an environment conducive to viral DNA replication.
EXPERIMENTAL PROCEDURES
Cells, Viruses, and Reagents
Human foreskin fibroblasts (passages 5–10) and 293T cells were cultured in
medium containing 10% newborn calf serum (NCS). To produce fibroblasts
expressing pUL38 (HFF-pUL38), the UL38 open reading frame was amplified
by PCR and cloned into pRetro-EBNA to make pRetroUL38. pRetroUL38
was transfected into the Phoenix Ampho packaging cells (Kinsella and Nolan,
1996) to generate retrovirus (RetroUL38), which was then used to infect fibro-
blasts. Control fibroblasts expressing green fluorescent protein (HFF-GFP)
were produced by infection with RetroGFP (Silva et al., 2005). More than
90% of cells expressed pUL38 or GFP.
BADWT is produced from a clone of the HCMV AD169 strain, pAD/Cre (Yu
et al., 2002). BADdlUL38 and BADinUL38TAP are derivatives of BADWT that
lack the UL38 coding region (Terhune et al., 2007) or contain a TAP tag fused
to the C terminus of the UL38 ORF (Supplemental Data).
Vectors expressing FLAG-tagged TSC1 and TSC2 (pRK7-FLAG-TSC1 and
pRK7-FLAG-TSC2; Tee et al., 2002) and EGFP-tagged TSC2 lacking the
TSC1-binding domain (EGFP-TSC2-DHBD; Goncharova et al., 2004) have
been described.
Rapamycin (20 nM; Cell Signaling Technology) was used to block mTORC1
function, and 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR, 5
mM; Cell Signaling Technology) was used to activate AMPK.
Mass Spectrometry Analysis of pUL38-Interacting Proteins
Fibroblasts, grown to 70% confluence, were mock infected or infected at
a multiplicity of 3 pfu/cell. After 24 hr, cells were washed with phosphate-buff-
ered saline (PBS) and harvested by scraping. After centrifugation at 1200 3 g
for 10 min at 4C, the cell pellet was weighed and resuspended (0.1 ml/g) in 20
mM HEPES (pH 7.5), containing 1.2% (w/v) polyvinylproline, 1/100 (v/v) prote-
ase inhibitor mixture (20mg/ml PMSF + 0.4mg/ml pepstatin A), and 1/200 (v/v)
protease inhibitor cocktail (Sigma). The cells were frozen as small pellets by
dropping into liquid nitrogen. Protein extraction, immunoaffinity purification,
gel electrophoresis, and mass spectrometric analysis (Supplemental Data)
have been described (Cristea et al., 2004, 2006; Cristea et al., 2005).
Protein Analysis
Proteins were analyzed by immunoprecipitation, western blot assay, and
immunofluorescence (Supplemental Data). Experiments utilized rabbit pep-
tide-specific, IgG antibodies from Cell Signaling Technologies: phospho-S6
260 Cell Host & Microbe 3, 253–262, April 2008 ª2008 Elsevier Inc.protein (S235/236) and S6 protein (#2211 and 2212), phospho-p70 S6 kinase
(T389) and p70 S6 kinase (#9205 and 2708), phospho-4E-BP1 (T37/46) and
4E-BP1(#9459 and 9452), phospho-Akt (S473) and Akt (#9271 and 9272),
and phospho-acetyl-coA carboxylase (S79) and acetyl-coA carboxylase
(#3661 and 3662); and from Santa Cruz Biotechnology: TSC2 (sc-893) and
normal rabbit IgG (sc-2027). Other experiments used mouse monoclonal anti-
bodies: anti-FLAG (M2, Sigma Aldrich) anti-pUL38 (8D6; Terhune et al., 2007);
anti- TSC1 (MAB5532, Upstate); and anti-tubulin (T6199, Sigma Aldrich).
Determination of Cell Volume
For measurement of cell volume by fluorescence, adherent cells were incu-
bated with calcein green AM for 1 hr at 37C, z-stack images (0.3 mm slices)
were collected through entire individual cells using an RS3 spinning disk
confocal microscope (Perkin Elmer), and fluorescent cell volume was calcu-
lated using Velocity 4.0 software (Improvision). For determination of relative
cell volume by flow cytometry, cells were removed from culture dishes by tryp-
sinization, and forward scatter was measured within 10 min by flow cytometry
(BD Biosciences FACScan). Larger cells have a greater forward scatter.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and
one supplemental table and can be found with this article online at http://
www.cellhostandmicrobe.com/cgi/content/full/3/4/253/DC1/.
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